BioNTech SE Rose over 6% in Morning Trading
BioNTech SE rose over 6% in morning trading as its Omicron-specific vaccines triggered high immune r
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial